Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Issue brief | 31 December 2017 142nd WHO EB Agenda item 6.2 - Global vaccine action plan VACCINES Download WHO-EB-142_MSF-Briefing-Global-Vaccine-Action-Plan_Agenda-Item-6-2 Photograph by Yann Libessart Global Vaccine Action Plan - WHO Executive Board, 142nd Session, January 2018 Provisional Agenda Item 6.2 (EB142/35)
